Indonesian Pharmacy Coronavirus Medication
As well as, Indonesian Pharmacy Coronavirus Medication. To anticipate the Coronavirus global pandemic, pharmaceutical industry players are trying to develop and distribute drugs to overcome the disease. Moreover, several types of drugs were reported by the World Health Organization (WHO) for handling COVID-19. Ferry Soetikno, Chairperson of Dexa Medica Group, said that for the moment there was no research plan for the development of the drug. But they have donate several types of drugs for hospital use in dealing with COVID-19 patients.
Coal Company Optimism amidst Coronavirus
IMPC and Subsidiaries
Coronavirus Delays Oil and Gas Project
Honesti Basyir, Director of Bio Farma, said that the pharmaceutical holding company of the State Owned Enterprise (SOE) has start to produce several types of drugs that are in line with the COVID-19 treatment protocol. Furthermore, oseltamivir is produced by Indofarma, then Hydroxychloroquine, Chloroquine and Azithromycin which are produced by Kimia Farma, he said. In addition to, Honesti was also reluctant to reveal further about the sale and price of the product.
Hantavirus as a Coronavirus 2.0
Perusahaan Gas Negara Force Majeure
SOEs Implements Social Distancing Coronavirus
Previously, it was report that the subsidiary of Bio Farma, namely Kimia Farma Tbk (KAEF IJ) was indeed further studying several types of COVID-19 drugs. Verdi Budidarmo, Director of KAEF said, the development was not easy in the midst of the supply of medicinal raw materials. As well as, more than 90% of which came from imports. For this short term, Kimia Farma has produce and distributed 13 million chloroquine tablets for 600 hospitals throughout Indonesia.
Toll Road Traffic and Coronavirus Outbreak
Motorcycle Industry Slowing Down
Indonesia: Coronavirus and Lockdown
Meanwhile, Kalbe Farma Tbk (KLBF IJ) has partner with a number of strategic partners both from within and outside the country to develop Coronavirus prevention research. Starting from initial research, clinical trials, drugs, medical devices, herbs, laboratory services and many others, add Vidjongtius, President Director of KLBF. Last, Kalbe also partner with Indonesian Institute of Sciences, Gadjah Mada University, and the Jamu Association for clinical trials.
